A Novel Marker for Screening Paroxysmal Nocturnal Hemoglobinuria Using Routine Complete Blood Count and Cell Population Data
활용도 Analysis
논문 Analysis
연구자 Analysis
저자
강지민
김용구
이종욱
고광상
김정옥
한경자
제어번호
101631827
학술지명
Annals of Laboratory Medicine
권호사항
Vol.
35
No.
1
[
2015
]
발행처
대한진단검사의학회
발행처 URL
http://www.kslm.org
자료유형
학술저널
수록면
35-40
언어
English
출판년도
2015
등재정보
KCI등재
소장기관
고려대학교 의학도서관
아주대학교 의학문헌정보센터
충남대학교 의학도서관
판매처
'
A Novel Marker for Screening Paroxysmal Nocturnal Hemoglobinuria Using Routine Complete Blood Count and Cell Population Data' 의 주제별 논문영향력
논문영향력 요약
주제
동일주제 총논문수
논문피인용 총횟수
주제별 논문영향력의 평균
7,576
0
자세히
주제별 논문영향력
논문영향력
주제
주제별 논문수
주제별 피인용횟수
주제별 논문영향력
주제분류(KDC/DDC)
의학
7,589
0
계
7,589
0
* 다른 주제어 보유 논문에서 피인용된 횟수
0
닫기
'
A Novel Marker for Screening Paroxysmal Nocturnal Hemoglobinuria Using Routine Complete Blood Count and Cell Population Data' 의 참고문헌
The “sugar-water” test for paroxysmal nocturnal hemoglobinuria
The “sugar-water” test for paroxysmal nocturnal hemoglobinuria
The molecular basis of paroxysmal nocturnal hemoglobinuria
The molecular basis of paroxysmal nocturnal hemoglobinuria
The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9
The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
Hillmen P
N Engl J Med 355 : 1233 ~ 1243
[2006]
The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria
Studies on destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: Certain immunological aspects of the hemolytic mechanism with special reference to serum complement
Ham TH
J Clin Invest 18 : 657 ~ 672
[1939]
Studies on destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: Certain immunological aspects of the hemolytic mechanism with special reference to serum complement
Ham TH
J Clin Invest 18 657-672
[1939]
Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anemia patients treated with combined immunosuppression: results of two-centre prospective study
Kulagin A
Br J Haematol 164 : 546 ~ 554
[2014]
Prognostic value of paroxysmal nocturnal haemoglobinuria clone presence in aplastic anemia patients treated with combined immunosuppression: results of two-centre prospective study
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia
Paroxysmal nocturnal hemoglobinuria: an historical overview
Parker CJ
Hematology Am SocHematolEduc Program : 93 ~ 103
[2008]
Paroxysmal nocturnal hemoglobinuria: a single Spanish center’s experience over the last 40 yr
Paroxysmal nocturnal hemoglobinuria: a single Spanish center’s experience over the last 40 yr
Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anaemia: a prospective single centre study
Timeus F
Br J Haematol 150 : 483 ~ 485
[2010]
Paroxysmal nocturnal hemoglobinuria clones in children with acquired aplastic anaemia: a prospective single centre study
Timeus F
Br J Haematol 150 483-485
[2010]
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
Paroxysmal nocturnal hemoglobinuria (PNH): higher sensitivity and validity in diagnosis and serial monitoring by flow cytometric analysis of reticulocytes
PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis
PIG-A mutations in paroxysmal nocturnal hemoglobinuria and in normal hematopoiesis
Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure
Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria
Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia
Minor population of CD55-CD59- blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival
How I treat paroxysmal nocturnal hemoglobinuria
How I treat paroxysmal nocturnal hemoglobinuria
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry
Borowitz MJ
Cytometry B ClinCytom 78 : 211 ~ 230
[2010]
Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry
Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis
Broséus J
Int J Lab Hematol 32 : 519 ~ 523
[2010]
Evaluation of mean sphered corpuscular volume for predicting hereditary spherocytosis
Broséus J
Int J Lab Hematol 32 519-523
[2010]
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
Diagnosis and management of paroxysmal nocturnal hemoglobinuria
Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria
Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria
Clinical utility of the new Beckman-Coulter parameter red blood cell size factor in the study of erithropoiesis
Clinical utility of the new Beckman-Coulter parameter red blood cell size factor in the study of erithropoiesis
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry
Lee JW
Int J Hematol 97 : 749 ~ 757
[2013]
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry
Lee JW
Int J Hematol 97 749-757
[2013]
Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal hemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anemia
Yoshida N
Br J Haematol 142 : 427 ~ 435
[2008]
Clinical impact of HLA-DR15, a minor population of paroxysmal nocturnal hemoglobinuria-type cells, and an aplastic anaemia-associated autoantibody in children with acquired aplastic anemia
Automated screening for tuberculosis by multiparametric analysis of data obtained during routine complete blood count
Park J
Int J Lab Hematol 36 : 156 ~ 164
[2014]
Automated screening for tuberculosis by multiparametric analysis of data obtained during routine complete blood count
Park J
Int J Lab Hematol 36 156-164
[2014]
Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link
Aplastic anemia and paroxysmal nocturnal hemoglobinuria: search for a pathogenetic link
A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure
Raza A
Cytometry B ClinCytom 86 : 175 ~ 182
[2014]
A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure
Raza A
Cytometry B ClinCytom 86 175-182
[2014]
'
A Novel Marker for Screening Paroxysmal Nocturnal Hemoglobinuria Using Routine Complete Blood Count and Cell Population Data'
의 유사주제(
) 논문